Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
home:mp:insurance [01.05.2014] – [Materials to present an insurer] joyfulhome:mp:insurance [09.14.2022] (current) – external edit 127.0.0.1
Line 40: Line 40:
 ===== Doctors have a right to exercise their judgment  ===== ===== Doctors have a right to exercise their judgment  =====
  
-According to a [[http://www.fda.gov/OC/OHRT/IRBS/offlabel.html|statement]] by the FDA, "Good medical practice and the best interests of the patient require that physicians use legally available drugs, biologics and devices according to their best knowledge and judgment."+According to a [[https://www.fda.gov/OC/OHRT/IRBS/offlabel.html|statement]] by the FDA, "Good medical practice and the best interests of the patient require that physicians use legally available drugs, biologics and devices according to their best knowledge and judgment."
  
 It is the doctor who has the license to practice medicine – not the insurance company! With the consent of the patient, it is the doctor's right and responsibility to decide which therapies a patient receives. If a doctor is williing to accept responsibility for the way he or she practices medicine, an insurance company has no right to interfere. It is the doctor who has the license to practice medicine – not the insurance company! With the consent of the patient, it is the doctor's right and responsibility to decide which therapies a patient receives. If a doctor is williing to accept responsibility for the way he or she practices medicine, an insurance company has no right to interfere.
Line 54: Line 54:
     * **Experimental** – Some insurers consciously do not cover medications considered experimental, so it is important not to use that word.     * **Experimental** – Some insurers consciously do not cover medications considered experimental, so it is important not to use that word.
     * **Off-label use** – In the context of the MP, referring Benicar use as off-label is ill-advised – even though off-label use of medications is [[home:mp:off-label|expressly permitted and encouraged]] by the FDA.     * **Off-label use** – In the context of the MP, referring Benicar use as off-label is ill-advised – even though off-label use of medications is [[home:mp:off-label|expressly permitted and encouraged]] by the FDA.
-  * **If accurate, a diagnosis of hypertension is helpful** – If a patient fits the criteria for diagnosis of hypertension, the FDA-approved indication for Benicar, and if the patient's blood pressure does not respond adequately to one 40mg tablet a day, then the package insert's [[http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021286s020lbl.pdf|prescribing instructions']] "Dosage and Administration" saying "dosage must be individualized." +  * **If accurate, a diagnosis of hypertension is helpful** – If a patient fits the criteria for diagnosis of hypertension, the FDA-approved indication for Benicar, and if the patient's blood pressure does not respond adequately to one 40mg tablet a day, then the package insert's [[https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021286s020lbl.pdf|prescribing instructions']] "Dosage and Administration" saying "dosage must be individualized." 
  
 <html> <html>
Line 60: Line 60:
 The label: The label:
  
-http://web.archive.org/web/20060309235055/http://www.fda.gov/medwatch/SAFETY/2004/nov_PI/Benicar_Tab_PI.pdf+https://web.archive.org/web/20060309235055/https://www.fda.gov/medwatch/SAFETY/2004/nov_PI/Benicar_Tab_PI.pdf
  
-http://www.drugs.com/pro/benicar.html+https://www.drugs.com/pro/benicar.html
 --> -->
 </html> </html>
Line 84: Line 84:
  
  
-  * {{pubmed>long:11361048}} +  * {{pmid>long:11361048}} 
-  * {{pubmed>long:15291377}}+  * {{pmid>long:15291377}}
  
-Efficacy of Benicar has been described in various conditions by a [[home:publications:waterhouse_annals_2009|forthcoming peer-reviewed paper]] in //Annals of the New York Academy of Sciences//. That paper will be available in the Fall of 2009. For a preprint – or for any other paper – ask on the [[http://marshallprotocol.com|MP study site]].+Efficacy of Benicar has been described in various conditions by a [[home:publications:waterhouse_annals_2009|forthcoming peer-reviewed paper]] in //Annals of the New York Academy of Sciences//. That paper will be available in the Fall of 2009. For a preprint – or for any other paper – ask on the [[https://marshallprotocol.com|MP study site]].
  
 ==== Letters to present to an insurance company ==== ==== Letters to present to an insurance company ====
Line 108: Line 108:
 ===== Read more ===== ===== Read more =====
  
-  * [[http://www.cnn.com/2007/HEALTH/07/19/patient.insurance/|Tips To Effectively Battle Your Insurance Company]]+  * [[https://www.cnn.com/2007/HEALTH/07/19/patient.insurance/|Tips To Effectively Battle Your Insurance Company]]
  
  
Line 122: Line 122:
  
  
-{{tag>Starting_the_Marshall_Protocol}}+{{tag>MP Starting_the_Marshall_Protocol}}
  
  
 +<nodisp>
 ===== Notes and comments ===== ===== Notes and comments =====
  
 +  * CureMyTh1.org references removed during transition to closing that site. --- //Joyful 01.04.2014//
  
   * Legacy content   * Legacy content
-    * http://www.marshallprotocol.com/forum2/304.html#p18560 e120  +    * https://www.marshallprotocol.com/forum2/304.html#p18560 e120  
-    * http://www.marshallprotocol.com/forum2/304.html e122  +    * https://www.marshallprotocol.com/forum2/304.html e122  
-    * http://www.marshallprotocol.com/view_topic.php?id=304&forum_id=2&jump_to=43440#p43440 e127  +    * https://www.marshallprotocol.com/view_topic.php?id=304&forum_id=2&jump_to=43440#p43440 e127  
-    * http://www.marshallprotocol.com/view_topic.php?id=304&forum_id=2&jump_to=111632#p111632 e132  +    * https://www.marshallprotocol.com/view_topic.php?id=304&forum_id=2&jump_to=111632#p111632 e132  
-    * http://www.marshallprotocol.com/forum2/398.html e255  +    * https://www.marshallprotocol.com/forum2/398.html e255  
-    * http://www.marshallprotocol.com/forum2/304.html#p79942 e130  +    * https://www.marshallprotocol.com/forum2/304.html#p79942 e130  
-    * http://www.marshallprotocol.com/view_topic.php?id=304&forum_id=2&jump_to=84963#p84963 e131 +    * https://www.marshallprotocol.com/view_topic.php?id=304&forum_id=2&jump_to=84963#p84963 e131 
-    * http://www.marshallprotocol.com/view_topic.php?id=304&forum_id=2&jump_to=35803#p35803 e126  +    * https://www.marshallprotocol.com/view_topic.php?id=304&forum_id=2&jump_to=35803#p35803 e126  
-    * http://www.marshallprotocol.com/forum2/304.html#p51098 e128+    * https://www.marshallprotocol.com/forum2/304.html#p51098 e128</nodisp> 
home/mp/insurance.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.